Accession Number: | 0000899243-20-018111 |
Date: | 2020-06-29 |
Issuer: | SERES THERAPEUTICS, INC. (MCRB) |
Original Submission Date: |
YOUNG TERESA L.
C/O SERES THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 4.67 | 2020-06-29 | deemed execution date | A | 300,000 (a) | 2030-06-28 | common stock 300,000 | $4.67 | 300,000 | direct |
ID | footnote |
---|---|
f1 | the option will vest as to 25% of the shares on june 29, 2021. the remainder of the shares will vest in 12 equal quarterly installments thereafter. |